EU scheme commits $350 mln to research Ebola vaccines and tests

LONDON, Nov 6 (Reuters) - The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) into Ebola research, with the lion's share going to fast-track the testing and manufacture of potential vaccines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.